Kjellson Nina S

DirectorTyra Biosciences, Inc. (TYRA) · full profile →Form 4 · filed Jan 21, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$410K
Net Open-Market Flow
-$410K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 21, 2025Sell(S)4K$16.36$65K3.7M
Jan 17, 2025Sell(S)461$16.40$8K447K
Jan 17, 2025Sell(S)13K$16.40$210K3.7M
Jan 16, 2025Sell(S)7K$16.29$113K3.7M
Jan 16, 2025Sell(S)835$16.29$14K448K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-007426) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about TYRA insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000950170-25-007426"
Ask your agent
Use Arkolith to summarize insider buying and selling at Tyra Biosciences, Inc.
over the last 90 days and cite the filings.